Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €118.40 EUR
Change Today +1.05 / 0.89%
Volume 2.2K
BAYA On Other Exchanges
As of 10:47 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

bayer ag-sponsored adr (BAYA) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/13/15 - €148.05
52 Week Low
10/16/14 - €97.10
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BAYER AG-SPONSORED ADR (BAYA)

bayer ag-sponsored adr (BAYA) Related Bloomberg News

View More Bloomberg News

bayer ag-sponsored adr (BAYA) Details

Bayer Aktiengesellschaft develops, produces, and markets health care and agricultural products, and high-tech polymer materials worldwide. The company operates through HealthCare, CropScience, and MaterialScience segments. The HealthCare segment offers prescription pharmaceuticals, such as anticoagulants; medicines to treat hemophilia, multiple sclerosis, cancer, eye diseases, pulmonary hypertension, high blood pressure, and infectious diseases; and contraceptives, as well as provides consumer health products, including over-the-counter medications, dermatology products, nutritional supplements, veterinary medicines, and animal grooming products. This segment also provides medical care products, including blood glucose monitoring devices, such as single-strip and multi-strip systems; USB meters that feature integrated diabetes management software and direct plug-in to computers; and contrast agent injection systems for diagnostic and therapeutic medical procedures in X-ray, computed tomography, and magnetic resonance imaging. The CropScience segment offers products in the areas of seeds and plant traits, and crop protection; and products for use in gardens and non-agricultural pest control, as well as green industry. The MaterialScience segment provides high-tech polymer materials in the areas of polyurethanes, polycarbonates, coating and adhesive raw materials, and specialty chemicals; and selected inorganic basic chemicals. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

117,798 Employees
Last Reported Date: 07/29/15
Founded in 1863

bayer ag-sponsored adr (BAYA) Top Compensated Officers

Chairman of Management Board and Chief Execut...
Total Annual Compensation: €3.2M
Chief Financial Officer and Member of Managem...
Total Annual Compensation: €520.0K
Chief Strategy & Portfolio Officer and Member...
Total Annual Compensation: €2.0M
Labor Director and Member of Management Board
Total Annual Compensation: €1.6M
Member of Management Board, Chief Medical Off...
Total Annual Compensation: €1.4M
Compensation as of Fiscal Year 2014.

bayer ag-sponsored adr (BAYA) Key Developments

Bayer AG Plans to List Bayer MaterialScience AG

Bayer AG (DB:BAYN) is seeking to float Bayer MaterialScience AG on the stock market by mid-2016 in order to concentrate exclusively on the life sciences businesses. Chief Executive Officer of Bayer MaterialScience said:"Independence will enable us to bring our strengths to bear in global competition more quickly, effectively and flexibly".

Bayer Group Opens its First Medical Devices Plant in Costa Rica

Bayer Group opened a plant for the production of a non-reversible permanent contraceptive device, with an investment of USD 12 million and an initial employment generation for up to 75 people. The plant located in the Zona Franca Metropolitana in Barreal de Heredia covers about 1,400 square meters, dedicated to the assembly of this medical device and has the ISO 13485 certification, which will allow Bayer to market this product in Europe and Canada. It also has the approval of the US Food and Drug Administration (FDA) to sell it in the United States.

Bayer AG Announces Directorate Changes

The Bayer AG announced the appointment of Jens Behrens as the director general and financial director of the Bayer company in Ukraine instead of Christoph Henze. Before the appointment Behrens had headed the corporate support service at the Bayer HealthCare business-group in China. He is also a member of the Bayer Global Leadership Circle group. Behrens had earlier worked for Bayer in Hong Kong, Taiwan, Japan, Europe and the United States. His total experience in the concern is over 30 years.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAYA:GR €118.40 EUR +1.05

BAYA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $60.73 USD +0.23
Allergan plc $296.48 USD +2.27
Amgen Inc $148.52 USD +1.06
GlaxoSmithKline PLC 1,320 GBp +24.50
Sanofi €87.24 EUR +1.24
View Industry Companies

Industry Analysis


Industry Average

Valuation BAYA Industry Range
Price/Earnings 28.7x
Price/Sales 2.2x
Price/Book 4.5x
Price/Cash Flow 28.7x
TEV/Sales 1.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-SPONSORED ADR, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at